Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AQNA-DY002: A Double-Masked, Randomized Study of the Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery

NCT00596492 is registered in ClinicalTrials.gov with Aqumen Biopharmaceuticals, N.A. as lead sponsor.

NCT NCT00596492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00596492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AQNA-DY002: A Double-Masked, Randomized Study of the Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery
Lead sponsor
Aqumen Biopharmaceuticals, N.A.
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2008
Completion date
December 31, 2008
Enrollment
200 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

mature cataracts